Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic advances in 2002 (1)].

A J Scheen1

  • 1Université de Liège, Service, Service de Médecine interne générale et Service de Diabétologie, Nutrition et Maladies métaboliques, Département de Médecine.

Revue Medicale De Liege
|February 5, 2003
PubMed
Summary

This review highlights key new internal medicine drugs launched in Belgium, detailing their characteristics and clinical use. Evidence-based medicine principles ensure their proven efficacy and safety for patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Clinical Practice

Context:

  • Overview of recent pharmaceutical advancements in Belgium.
  • Focus on drugs relevant to internal medicine disciplines.
  • Emphasis on practical application in clinical settings.

Purpose:

  • To describe the most significant drugs registered or launched in Belgium recently.
  • To detail the primary characteristics and appropriate clinical use of these new molecules.
  • To underscore the evidence-based foundation of their efficacy and safety.

Summary:

  • Presents a curated selection of important new drugs for internal medicine in Belgium.
  • Highlights key molecular features and recommended clinical application strategies.
  • Confirms efficacy and tolerance based on randomized clinical trials and evidence-based medicine.

Impact:

  • Facilitates informed decision-making for clinicians regarding new therapeutic options.
  • Supports the integration of novel, evidence-based treatments into Belgian healthcare.
  • Enhances understanding of the latest advancements in internal medicine pharmacotherapy.

Related Experiment Videos